Patent ID: 9603832
Date: 2017-03-28
CPC Classifications: A61K,A61P,C07C,C07D

Claim:
1. A method for modulating voltage gated sodium and/or calcium channels, comprising the step of administering to a patient in need thereof an effective amount of a compound of formula (I): wherein: X is —O—; Y is hydrogen, —OH or —O(C Z is ═O or ═S; R is —(C R group where R R R R its pharmaceutically acceptable salts and the isolated optical isomers or mixtures of optical isomers of the compound and their pharmaceutically acceptable salts, wherein a disorder treatable by such modulation is an immunological or endocrinological disorder selected from periarthritis nodosa, thyroiditis, aplastic anaemia, sclerodoma, myasthenia gravis, multiple sclerosis and other demyelinating disorders, encephalomyelitis, sarcoidosis, nephritic syndrome, Bechet's syndrome, polymyositis and gingivitis.